SCHEMBL17300222

SCHEMBL17300222

c1ccc(-c2ccc3c(c2)nc(-c2cccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c2)c2c4ccccc4c4ccccc4c32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.41
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ ATM Q13315 1/20 0.40
▸ WHR1 P49842 1/20 0.38
▸ PIK3R1 P27986 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ LMNA P02545 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ CYP1A2 P05177 3/20 0.34
▸ CYP3A4 P08684 3/20 0.34
▸ CYP2C9 P11712 3/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CLK4 Q9HAZ1 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17914804 0.93 MEN1 (0.47) MEN1KMT2AATMWHR1ALDH1A1
SCHEMBL17915195 0.93 MEN1 (0.47) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL17915008 0.92 MEN1 (0.49) MEN1KMT2AATMWHR1ALDH1A1
SCHEMBL17915199 0.92 MEN1 (0.44) MEN1KMT2AATMWHR1ALDH1A1
SCHEMBL17300228 0.92 MEN1 (0.48) DHFRMEN1KMT2AATMWHR1
SCHEMBL23861188 0.91 ABCG2 (0.40) DHFRMEN1KMT2AATMWHR1
SCHEMBL17300221 0.91 CYP1A2 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL23861220 0.90 LMNA (0.36) DHFRMEN1KMT2AATMWHR1
SCHEMBL17914801 0.90 MEN1 (0.45) MEN1KMT2AATMWHR1ALDH1A1
SCHEMBL23861234 0.90 ABCG2 (0.41) MEN1KMT2AATMWHR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10608189-B2 Condensed cyclic compounds and organic light-emitting devices including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-31 — — US disclosed
US-20150349275-A1 CONDENSED CYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-03 — — US disclosed
US-20150349275-A1 CONDENSED CYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10608189-B2 Condensed cyclic compounds and organic light-emitting devices including the same CRY1, CRY2, CCNE2 DHFR 1744/4885MEN1 400/4885KMT2A 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback